Liver Diseases: all 2,094 studies
Page 7 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of AfatinibCompletedNCT01298063Phase 1Results posted
- Insulin Resistance in Non-alcoholic Fatty Liver DiseaseTerminatedNCT01289639Not applicableResults posted
- Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) StudyCompletedNCT01285362Not applicableResults posted
- Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver DiseaseCompletedNCT01284634Phase 2Results posted
- The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)CompletedNCT01265498Phase 2Results posted
- Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)TerminatedNCT01244503Phase 2Results posted
- Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United KingdomCompletedNCT01202253Results posted
- Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver SurgeryCompletedNCT01099475Not applicableResults posted
- Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm NeonatesCompletedNCT01050660Not applicableResults posted
- LAGB as a Treatment for Morbid Obesity in AdolescentsCompletedNCT01045499Not applicableResults posted
- Isoflurane Preconditioning for Liver ResectionsTerminatedNCT01031550Not applicableResults posted
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver DiseaseCompletedNCT01006889Phase 4Results posted
- Markers of Liver Apoptosis After Anesthesia With Sevoflurane or PropofolCompletedNCT01000337Not applicableResults posted
- University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)CompletedNCT00994682Phase 4Results posted
- Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver DiseaseCompletedNCT00949403Early Phase 1Results posted
- Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT00940537Results posted
- Polycystic Liver Disease in Kidney TransplantTerminatedNCT00934791Not applicableResults posted
- Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic ProceduresCompletedNCT00914927Phase 2Results posted
- Cholestasis Reversal: Efficacy of IV Fish OilCompletedNCT00910104Phase 2/3Results posted
- Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver DiseaseCompletedNCT00862446Phase 4Results posted
- Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver DiseaseCompletedNCT00861601Phase 2Results posted
- Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced CholestasisCompletedNCT00826020Phase 2Results posted
- Study of Lactulose in Children With Chronic Liver DiseaseTerminatedNCT00811434Phase 2Results posted
- Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty AcidsCompletedNCT00760513Phase 4Results posted
- Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C InfectionsTerminatedNCT00742326Phase 4Results posted
- BreathID 13C-Methacetin Breath Test for Detecting CirrhosisCompletedNCT00736840Phase 3Results posted
- Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)TerminatedNCT00736385Phase 4Results posted
- Hepatic Effects of Gastric Bypass SurgeryCompletedNCT00701376Not applicableResults posted
- Human Tissue Distribution of Orally Supplemented Natural Vitamin E TocotrienolCompletedNCT00678834Early Phase 1Results posted
- Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTerminatedNCT00678587Phase 3Results posted
- A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver InsufficiencyCompletedNCT00655707Phase 1/2Results posted
- Role of Exenatide in NASH-a Pilot StudyCompletedNCT00650546Phase 2/3Results posted
- Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)CompletedNCT00596934Phase 2Results posted
- Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaTerminatedNCT00588146Phase 2Results posted
- Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)CompletedNCT00586313Not applicableResults posted
- Effects of SAMe in Patients With Alcoholic Liver DiseaseCompletedNCT00573313Phase 3Results posted
- Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver DiseaseCompletedNCT00543777Phase 1/2Results posted
- Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver DiseaseTerminatedNCT00529204Phase 2Results posted
- Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative TherapyCompletedNCT00526331Phase 4Results posted
- Octreotide in Severe Polycystic Liver DiseaseCompletedNCT00426153Phase 2/3Results posted
- Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.CompletedNCT00298363Phase 2Results posted
- Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASHCompletedNCT00267670Phase 2/3Results posted
- Obesity and Nonalcoholic Fatty Liver DiseaseCompletedNCT00262964Not applicableResults posted
- Insulin Resistance in Non-alcoholic Fatty Liver DiseaseTerminatedNCT00252499Not applicableResults posted
- Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver TransplantationCompletedNCT00206076Phase 4Results posted
- Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C InfectionCompletedNCT00163657Phase 4Results posted
- Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic ImpairmentCompletedNCT00162097Phase 1Results posted
- Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation PatientsCompletedNCT00105235Phase 2Results posted
- Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)CompletedNCT00078403Phase 2Results posted
- Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)CompletedNCT00063635Phase 3Results posted
- Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)CompletedNCT00063622Phase 3Results posted
- Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic DisordersCompletedNCT07646015
- The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate ReferralCompletedNCT07580482Not applicable
- Impact of Delta Model of End Stage Liver Disease (MELD) in High MELD Liver Transplant RecipientsCompletedNCT07570901
- Assessing Changes in Gadoxetate Metabolism by the Liver Using MRICompletedNCT07541807
- A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic FunctionCompletedNCT07428525Phase 1
- Donor and Recipient Mismatch in Liver TransplantationCompletedNCT07250919
- Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical TrialActive, not recruitingNCT07226622
- Intubation Conditions During ERCP With Lidocaine Aerosol Plus Low-dose Cisatracurium or Conventional-dose CisatracuriumCompletedNCT07185074Phase 4
- A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV InfectionActive, not recruitingNCT07142811Phase 2
- A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With BulevirtideActive, not recruitingNCT07128550Phase 3
- Long-Term Outcomes of ABO-Incompatible Versus Compatible Living Donor Liver TransplantationTerminatedNCT07105085
- A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral DoseCompletedNCT07102095Phase 1
- Home-based EXercise and motivAtional Program Before and After Liver TransplantationActive, not recruitingNCT07063940Not applicable
- A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.CompletedNCT07037394Phase 4
- Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using FibroscanCompletedNCT07027332
- Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).Active, not recruitingNCT07020377Phase 1/2
- Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver ResectionsCompletedNCT06980571Not applicable
- Mechanisms of Macrophage Polarization in HIRI in Patients With NAFLDActive, not recruitingNCT06950710
- Effects of Hepatic Impairment on the Pharmacokinetics of DazucorilantCompletedNCT06928779Phase 1
- A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver FunctionCompletedNCT06916078Phase 1
- The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic SteatohepatitisActive, not recruitingNCT06913699
- FibroScan-Reproducibility and Repeatability StudyCompletedNCT06877026Not applicable
- Chronic Liver Disease and Radiation-induced Second Primary Liver MalignancyCompletedNCT06868394
- Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink TechnologyActive, not recruitingNCT06865898
- Risk of MASLD in Adults in RomaniaCompletedNCT06864845
- Achieving Portal Access With Scorpion Post-Approval Study 2CompletedNCT06856655
- Validation of New Prognostic Biomarkers in Patients With Decompensated CirrhosisCompletedNCT06855056
- Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver DiseasesCompletedNCT06829966
- Serum Zinc and Serum Magnesium in Chronic Liver Disease PatientsCompletedNCT06827769
- RTX001 Autologous Engineered Macrophages for Liver CirrhosisActive, not recruitingNCT06823713Phase 1/2
- Variants Of Intrahepatic Biliary Radicals in Nepali PopulationCompletedNCT06793007
- A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up DatabaseCompletedNCT06741111
- Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.CompletedNCT06736340Phase 1
- A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver ProblemsCompletedNCT06692322Phase 1
- A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASHWithdrawnNCT06692283Phase 3
- NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic PatientsCompletedNCT06688149Not applicable
- Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Mild, Moderate and Normal Hepatic ImpairmentCompletedNCT06671509Phase 1
- Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver PatientsCompletedNCT06666894Not applicable
- Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLDActive, not recruitingNCT06662851
- New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)CompletedNCT06647095
- Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver DiseaseActive, not recruitingNCT06623539Phase 2
- Tocotrienol as a Treatment for Non-alcoholic Fatty Liver DiseaseCompletedNCT06596382Not applicable
- Maternal And Fetal Outcomes in Pregnant Women With Liver DiseaseCompletedNCT06594237
- Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in EthiopiaActive, not recruitingNCT06586983
- Dietary Intervention for Low Free Sugars in Children With Non-alcoholic Fatty Liver DiseaseCompletedNCT06579729Not applicable
- Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780CompletedNCT06576765Phase 1
- Ultrasound and Attenuation ImagingCompletedNCT06552377
- Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic ImpairmentCompletedNCT06535399Phase 1
- Impact of Fatty Liver on Hepatitis B TherapyActive, not recruitingNCT06535048